首页|期刊导航|四川中医|基于文献分析及网络药理学探究柴芍六君子汤治疗卒中后抑郁共病失眠的作用机制

基于文献分析及网络药理学探究柴芍六君子汤治疗卒中后抑郁共病失眠的作用机制OA

Elucidating the mechanism of Chaishao Liujunzi Decoction in treating post-stroke depression comorbid with insomnia based on literature analysis and network pharmacology

中文摘要英文摘要

目的 本研究基于文献分析与网络药理学系统探究柴芍六君子汤(CSLJZT)拆分的疏肝理气组、健脾益气组、和胃化痰组及全方组治疗卒中后抑郁(PSD)共病失眠的作用机制.方法 依据中医组方理论将 CSLJZT进行分组,基于 TCMSP 筛选 CSLJZT 的活性成分与潜在靶点,通过 GeneCards、OMIM、Disgenet、TTD 数据库进行靶点预测,以识别 PSD 共病失眠相关基因,通过 Venn 图分析得到中药复方各组与疾病的交集靶点.利用Cytoscape 构建"药物-活性成分-靶点"网络,并分析蛋白质-蛋白质相互作用(PPI)网络,以识别各组核心靶点.进行GO和KEGG通路富集分析,探索相关生物过程和信号通路.结果 根据组方理论将CSLJZT分为疏肝理气组(柴胡、白芍)、健脾益气组(人参、茯苓、白术、甘草)、和胃化痰组(半夏、陈皮)及 CSLJZT 全方,与共病的交集靶点分别为 138 个、161 个、91 个和 173 个.关键活性成分包括槲皮素、山奈酚、β-谷甾醇、7-甲氧基-2-甲基异黄酮、川陈皮素、异鼠李素、鹰嘴豆芽素 A、芒柄花素等;核心靶点如 TP53、AKT1、JUN、STAT3、IL6、TNF、MAPK1/3、HSP90AA1、ESR1、BCL2 等.富集分析表明,疏肝理气组、健脾益气组及全方主要富集于脂质与动脉粥样硬化、AGE-RAGE 等通路,共同调控神经炎症、细胞凋亡与氧化应激;而和胃化痰组则富集于神经活性配体-受体相互作用通路,提示其通过调节神经递质稳态发挥作用.结论 柴芍六君子汤通过多组分、多靶点、多通路整合机制,治疗 PSD 共病失眠,其中疏肝理气组、健脾益气组主要通过神经炎症、细胞凋亡、氧化应激等信号通路,发挥抗炎、调控细胞凋亡、抗氧化及促进神经和血管再生的作用,而和胃化痰组则侧重调节神经递质发挥调节睡眠、抗抑郁、抗炎的作用,从而印证了其"调肝-治脾-和胃"的中医治疗原则,并揭示了其现代科学内涵.

Objective This study systematically investigated the mechanisms of different fractions of Chaishao Liujunzi Decoction(CSLJZT)in treating post-stroke depression(PSD)comorbid with insomnia,based on literature analysis and network pharmacology.Methods CSLJZT was divided into groups according to traditional Chinese medicine(TCM)formulation principles.Active ingredients and potential targets of CSLJZT were screened using the TCMSP database.Disease-related targets for PSD comorbid with insomnia were predicted via GeneCards,OMIM,Disgenet,and TTD databases.Venn diagrams were used to identify overlapping targets between each herbal fraction and the disease.A"drug-active ingredient-target"network was constructed using Cytoscape,and protein-protein interaction(PPI)networks were analyzed to identify core targets.Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment analyses were performed to explore relevant biological processes and signaling pathways.Results According to TCM formulation theory,CSLJZT was divided into SGLQ group(Bupleurum,Paeonia lactiflora),JPYQ group(Ginseng,Poria,Atractylodes and Glycyrrhiza),HWHT group(Pinellia,Citrus reticulata)and the full CSLJZT group.The overlapping targets with the comorbid disease were 138,161,91,and 173,respectively.Key active ingredients included quercetin,kaempferol,β-sitosterol,7-methoxy-2-methyl isoflavone,nobiletin,isorhamnetin,biochanin A,formononetin,etc.Core targets included TP53,AKT1,JUN,STAT3,IL6,TNF,MAPK1/3,HSP90AA1,ESR1,BCL2,etc.Enrichment analysis indicated that SGLQ group,JPYQ group and full formula groups were mainly enriched in pathways such as lipid and atherosclerosis,and AGE-RAGE,collectively regulating neuroinflammation,apoptosis,and oxidative stress.In contrast,HWHT group was enriched in the neuroactive ligand-receptor interaction pathway,suggesting its role in modulating neurotransmitter homeostasis.Conclusion CSLJZT treats PSD comorbid with insomnia through an integrated multi-component,multi-target,multi-pathway mechanism.The SGLQ group and JPYQ group primarily exert anti-inflammatory,apoptosis-regulatory,antioxidant,and neurovascular regenerative effects via signaling pathways related to neuroinflammation,apoptosis,and oxidative stress.Meanwhile,HWHT group mainly regulates neurotransmitters to improve sleep,alleviate depression,and reduce inflammation.These findings validate the TCM treatment principle of"soothing the liver,strengthening the spleen,and harmonizing the stomach,"while elucidating its modern scientific basis.

尹婉君;何志传;谭静

东莞市中西医结合医院,广东 东莞 523000广州中医药大学东莞医院,广东 东莞 523000东莞市中西医结合医院,广东 东莞 523000

医药卫生

柴芍六君子汤卒中后抑郁失眠文献探究网络药理学作用机制

Chaishao Liujunzi decoctionPost-stroke depressionInsomniaLiterature reviewNetwork pharmacologyMechanism of action

《四川中医》 2026 (3)

81-94,14

东莞市社会科技发展重点项目(202050715002182).

10.26946/j.cnki.1000-3649.sczy.2509280002

评论